Literature DB >> 22821917

Structural brain MR imaging changes associated with obsessive-compulsive disorder in patients with multiple sclerosis.

E Tinelli1, A Francia, E M Quartuccio, M Morreale, G M Contessa, S Pascucci, E Sbardella, C Pozzilli, P Pantano.   

Abstract

BACKGROUND AND
PURPOSE: Psychiatric symptoms occur in approximately 30% of patients with MS. Such symptoms include OCD, which may interfere heavily with the patient's daily life. We hypothesized that the widespread involvement of both GM and WM, which characterizes MS, may be responsible for the occurrence of OCD when specific brain structures are affected. The aim of this study was to evaluate the relationship between GM and WM tissue damage and OCD in patients with MS.
MATERIALS AND METHODS: We evaluated 16 patients with relapsing-remitting MS who had been diagnosed with OCD on the basis of the Diagnostic and Statistical Manual of Mental Disorders (4th edition) and 15 age- and sex-matched patients with relapsing-remitting MS with no psychiatric disorders as a CG. The MR study (1.5T) included 3D T1-weighted fast-field echo sequences, DTI (32 directions), and conventional MRI. Images were processed using SPM5, FSL, and Jim 5.0 software to evaluate VBM, TBSS, and global and regional LV, respectively.
RESULTS: The VBM analysis revealed a set of clusters of reduced GM volume in the OCD group, compared with the CG, located in the right inferior and middle temporal gyri and in the inferior frontal gyrus. TBSS did not detect any differences in the FA values between the 2 groups; global and regional LV values also did not differ significantly between the 2 groups.
CONCLUSIONS: Our study suggests that OCD in MS may be caused by damage in the right frontotemporal cortex.

Entities:  

Mesh:

Year:  2012        PMID: 22821917      PMCID: PMC7965097          DOI: 10.3174/ajnr.A3210

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

1.  The assessment of anxiety states by rating.

Authors:  M HAMILTON
Journal:  Br J Med Psychol       Date:  1959

2.  Neuropsychological and psychiatric profiles in acute encephalitis in adults.

Authors:  Stephen M Pewter; W Huw Williams; Catherine Haslam; Janice M Kay
Journal:  Neuropsychol Rehabil       Date:  2007 Aug-Oct       Impact factor: 2.868

3.  Anatomical alterations and symptom-related functional activity in obsessive-compulsive disorder are correlated in the lateral orbitofrontal cortex.

Authors:  Jean-Yves Rotge; Nicolas Langbour; Nematollah Jaafari; Dominique Guehl; Bernard Bioulac; Bruno Aouizerate; Michele Allard; Pierre Burbaud
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

Review 4.  Multiple sclerosis and depression.

Authors:  Anthony Feinstein
Journal:  Mult Scler       Date:  2011-11       Impact factor: 6.312

5.  Psychotic disorders in MS: population-based evidence of an association.

Authors:  Scott B Patten; Lawrence W Svenson; Luanne M Metz
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

6.  Microstructural brain abnormalities in patients with obsessive-compulsive disorder: diffusion-tensor MR imaging study at 3.0 T.

Authors:  Fei Li; Xiaoqi Huang; Yanchun Yang; Bin Li; Qizhu Wu; Tijiang Zhang; Su Lui; Graham J Kemp; Qiyong Gong
Journal:  Radiology       Date:  2011-04-07       Impact factor: 11.105

Review 7.  Recognizing and treating common psychiatric disorders in multiple sclerosis.

Authors:  Jeffrey A Wilken; Cynthia Sullivan
Journal:  Neurologist       Date:  2007-11       Impact factor: 1.398

8.  Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis.

Authors:  Jean-Yves Rotge; Nicolas Langbour; Dominique Guehl; Bernard Bioulac; Nematollah Jaafari; Michele Allard; Bruno Aouizerate; Pierre Burbaud
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

9.  Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data.

Authors:  Stephen M Smith; Mark Jenkinson; Heidi Johansen-Berg; Daniel Rueckert; Thomas E Nichols; Clare E Mackay; Kate E Watkins; Olga Ciccarelli; M Zaheer Cader; Paul M Matthews; Timothy E J Behrens
Journal:  Neuroimage       Date:  2006-04-19       Impact factor: 6.556

10.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

View more
  5 in total

Review 1.  Psychiatric disorders in multiple sclerosis.

Authors:  Maddalena Sparaco; Luigi Lavorgna; Simona Bonavita
Journal:  J Neurol       Date:  2019-06-13       Impact factor: 4.849

2.  Structural abnormalities and altered regional brain activity in multiple sclerosis with simple spinal cord involvement.

Authors:  Ping Yin; Yi Liu; Hua Xiong; Yongliang Han; Shambhu Kumar Sah; Chun Zeng; Jingjie Wang; Yongmei Li
Journal:  Br J Radiol       Date:  2018-01-31       Impact factor: 3.039

3.  Self-Injurious Behavior Revealing Advanced Primary Progressive Multiple Sclerosis with a Massive Right Temporal Lesion.

Authors:  Markus Gschwind; Agustina Maria Lascano; Gürkan Kaya; Frederic Assal
Journal:  J Clin Neurol       Date:  2018-04       Impact factor: 3.077

4.  STAT3 and NTRK2 Genes Predicted by the Bioinformatics Approach May Play Important Roles in the Pathogenesis of Multiple Sclerosis and Obsessive-Compulsive Disorder.

Authors:  Ali Sepehrinezhad; Ali Shahbazi; Ali Bozorgmehr; Babak Kateb; Vicky Yamamoto; Sajad Sahab Negah
Journal:  J Pers Med       Date:  2022-06-26

5.  Morphostructural MRI abnormalities related to neuropsychiatric disorders associated to multiple sclerosis.

Authors:  Simona Bonavita; Gioacchino Tedeschi; Antonio Gallo
Journal:  Mult Scler Int       Date:  2013-04-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.